26 Participants Needed

Walking Intervention for Cognitive Impairment

(OASIS Trial)

Recruiting at 1 trial location
KS
TJ
Overseen ByTracey JF Colella, PhD
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: University Health Network, Toronto
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the OASIS Walking Intervention treatment for cognitive impairment?

Research shows that walking programs can help maintain or improve daily activities and slow cognitive decline in people with Alzheimer's and mild cognitive impairment. A study found that a six-month walking program improved daily activities and slowed cognitive decline in Alzheimer's patients, suggesting that regular walking may benefit those with cognitive challenges.12345

Is the Walking Intervention for Cognitive Impairment safe for humans?

Research shows that walking interventions, including those using virtual reality or prompting devices, are generally safe for older adults with cognitive impairments. Studies found no major adverse events, and participants were able to complete the programs successfully.16789

How is the OASIS Walking Intervention treatment different from other treatments for cognitive impairment?

The OASIS Walking Intervention is unique because it focuses on a structured walking program to help maintain cognitive function and daily living activities in people with cognitive impairment, unlike other treatments that may not emphasize physical activity. This approach is based on evidence that regular walking can improve mobility and slow cognitive decline, particularly in older adults with conditions like Alzheimer's disease.124510

What is the purpose of this trial?

The goal of this intervention study is to test the effects of a nurse-led mobility intervention (known as the OASIS Walking Intervention (Older Adults performing Sit to Stands and Walking Intervention)) in older adults with cognitive impairment, such as dementia, in transitional care programs.The main questions this study aims to answer are:* Is the study doable and are older adults satisfied with the intervention?* Does the intervention improve older adults' muscle strength, mobility, functional status and quality of life?Participants will be asked to do the following:1. Be interviewed once so that a patient-centred communication care plan can be made2. Do sit to stand activity3. Walk as part of a walking program.

Research Team

KS

Katherine S McGilton, PhD

Principal Investigator

University Health Network, Toronto

Eligibility Criteria

This trial is for older adults aged 65 and over with cognitive impairments like dementia, who were living at home before hospitalization. They must be able to walk (with or without help), speak English, have a care partner willing to interview, and get clearance from both a physiotherapist and nurse practitioner.

Inclusion Criteria

Were community-dwelling prior to hospitalization
I could walk by myself or with someone's help before I was admitted to the hospital.
My physiotherapist has approved my participation in this study.
See 6 more

Exclusion Criteria

I have been diagnosed with Parkinson's disease.
Palliative (having <six months prognosis as documented in the medical chart)

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants engage in the OASIS Walking Intervention, which includes a Patient-Centered Communication Care Plan, Sit to Stand Activity, and Walking Program.

6 weeks for Long-term Care Stream or Rehab Stream; 3 weeks for Reactivation Stream
5 sessions per week

Follow-up

Participants are monitored for satisfaction, muscle strength, mobility, functional status, and quality of life after the intervention.

4 weeks

Treatment Details

Interventions

  • OASIS Walking Intervention
Trial Overview The study tests the OASIS Walking Intervention which includes sit-to-stand exercises and walking programs led by nurses. It aims to see if this can improve muscle strength, mobility, functional status, and quality of life in cognitively impaired seniors.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Reactivation Stream Intervention ArmExperimental Treatment1 Intervention
Intervention Dose: up to 45 minutes per session, five sessions per week, for 3 weeks. Approximately up to 30 minutes will be spent walking with the participant and up to 15 minutes will be spent performing the sit-to-stands. Component 1: Patient-Centered Communication Care Plan. A patient-centered communication care plan will be created, to promote enjoyment and engagement during the sessions. The care plan will be informed by interviews with the participant and their care partner. Component 2: Sit to Stand Activity. A target number of sit to stands per session will be determined based on a baseline assessment and according to an algorithm; the target will be progressed halfway into the intervention. Component 3: Walking Program. Based on the findings from the patient-centered assessment interviews as well as the performance of the participants on a walk test at baseline (Time 1), an individualized walking program will be carried out with participants.
Group II: Long-term Care Stream or Rehab Stream Intervention ArmExperimental Treatment1 Intervention
Intervention Dose: Up to 45 minutes per session, 5 sessions per week, for 6 weeks. Approximately up to 30 minutes will be spent walking; up to 15 minutes will be spent performing sit-to-stands. Intervention Components: Component 1: Patient-Centered Communication Care Plan. A patient-centered communication care plan will be created, to promote enjoyment and engagement during the sessions. The care plan will be informed by interviews with the participant and their care partner. Component 2: Sit to Stand Activity. A target number of sit to stands per session will be determined based on a baseline assessment and according to an algorithm; the target will be progressed halfway into the intervention. Component 3: Walking Program. Based on the findings from the patient-centered assessment interviews as well as the performance of the participants on a walk test at baseline (Time 1), an individualized walking program will be carried out with participants.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University Health Network, Toronto

Lead Sponsor

Trials
1,555
Recruited
526,000+

Canadian Institutes of Health Research (CIHR)

Collaborator

Trials
1,417
Recruited
26,550,000+

Findings from Research

The multifaceted walking intervention (MWI) was highly feasible and acceptable, with 86% recruitment and 94% adherence rates among 25 long-term care residents with dementia over a 4-month period.
Participants showed significant improvements in functional mobility and quality of life, including faster Timed Up-and-Go times and increased distances in the Two-Minute Walk Test, indicating that person-centered physical activity can effectively support residents with dementia.
A Feasibility Study of a Multifaceted Walking Intervention to Maintain the Functional Mobility, Activities of Daily Living, and Quality of Life of Nursing Home Residents With Dementia.Chu, CH., Puts, M., Brooks, D., et al.[2021]
A systematic review of 36 studies found that exercise programs focusing on strength and balance, especially when combined with functional mobility training, significantly improve gait in older adults with mild cognitive impairment or dementia.
Cognitive training should be integrated with physical exercises to enhance gait performance, particularly focusing on attention and executive function, as this combination helps older adults apply their training to daily activities.
Interventions to Improve Gait in Older Adults with Cognitive Impairment: A Systematic Review.Zhang, W., Low, LF., Gwynn, JD., et al.[2021]
Exercise-based therapy can potentially improve health for individuals with Mild Cognitive Impairment (MCI) or dementia, but adherence to these exercise programs is a significant challenge.
Fifteen different strategies were evaluated to support adherence, with music being the only strategy shown to be effective in a comparative design, but only for those already interested in activities, highlighting the need for more robust evidence on adherence strategies.
Adherence support strategies for exercise interventions in people with mild cognitive impairment and dementia: A systematic review.van der Wardt, V., Hancox, J., Gondek, D., et al.[2021]

References

A Feasibility Study of a Multifaceted Walking Intervention to Maintain the Functional Mobility, Activities of Daily Living, and Quality of Life of Nursing Home Residents With Dementia. [2021]
Interventions to Improve Gait in Older Adults with Cognitive Impairment: A Systematic Review. [2021]
Adherence support strategies for exercise interventions in people with mild cognitive impairment and dementia: A systematic review. [2021]
Six-month walking program changes cognitive and ADL performance in patients with Alzheimer. [2022]
Feasibility and effectiveness of a walking program for community-dwelling older adults with mild cognitive impairment. [2019]
The Use of Home-Based Nonimmersive Virtual Reality to Encourage Physical and Cognitive Exercise in People With Mild Cognitive Impairment: A Feasibility Study. [2022]
Physical inactivity in older adults with cognitive impairment without dementia: room for improvement. [2023]
Home-based exercise program for older adults with Motoric Cognitive Risk syndrome: feasibility study. [2021]
REducing SEDENTary Behavior Among Mild to Moderate Cognitively Impaired Assisted Living Residents: A Pilot Randomized Controlled Trial (RESEDENT Study). [2022]
Effect of a multifactorial interdisciplinary intervention on mobility-related disability in frail older people: randomised controlled trial. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security